Trial Profile
A Phase 1, Single-Dose, Open-Label, 3-Period, Randomized Crossover Study to Assess the Relative Bioavailability Across Three Strengths of a New ASP015K Tablet Formulation in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Peficitinib (Primary)
- Indications Plaque psoriasis; Transplant rejection
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 08 Dec 2011 New trial record